The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, ...

The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the ...

The F.D.A. authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a ...

chronic (long-term) respiratory disease, such as asthma (requires continuous or repeated use of inhaled or systemic steroids ...

Roche RHHBY announced positive top-line results from a late-study on influenza drug, Xofluza. The CENTERSTONE study was a global phase III trial investigating the efficacy of single-dose Xofluza, ...

It is not inevitable that H5N1 will develop into a pandemic -- if we act now. Unfortunately, instead of urgent action, we ...

The leading cause for NHS staff absences was psychiatric illnesses, with 25.6% naming it as their reason for taking time off.

Roche announces phase III CENTERSTONE study of Xofluza significantly reduces the transmission of influenza viruses: Basel Friday, September 20, 2024, 09:00 Hrs [IST] Roche announc ...

The Centers for Disease Control is warning that a drop in vaccinations in the U.S. may have increased flu deaths among ...

Data from the CENTERSTONE study shows single-dose Xofluza reduces transmission of influenza from an infected person to household membersThis is the first time that any antiviral used in the treatment ...

Data from the CENTERSTONE study shows single-dose Xofluza reduces transmission of influenza from an infected person to ...

It may surprise you to learn that this seemingly common respiratory infection can significantly increase your risk of a heart ...